Protein kinase D enzymes: Novel kinase targets in pancreatic cancer

Geou Yarh Liou, Peter Storz

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pancreatic ductal adenocarcinoma (PDA) is characterized by advanced stage desmoplastic tumors with a high prevalence of genetic abnormalities. Occurrence of PDA is linked to activating Kras mutations and aberrant epidermal growth factor receptor signaling, leading to additional activation of wild-type Kras. As Kras is difficult to target, there is a constant need to identify novel targets acting downstream of this molecule in driving the formation or progression of PDA. Recently, it was shown that protein kinase D enzymes not only are increasingly expressed in PDA but also causatively linked to the development and progression of this cancer. They act downstream of both mutant Kras and growth factors and therefore may represent ideal novel targets.

Original languageEnglish (US)
Pages (from-to)1143-1146
Number of pages4
JournalExpert Review of Gastroenterology and Hepatology
Volume9
Issue number9
DOIs
StatePublished - Sep 2 2015

Fingerprint

4 alpha-glucanotransferase
Pancreatic Neoplasms
Adenocarcinoma
Phosphotransferases
Epidermal Growth Factor Receptor
Neoplasms
Intercellular Signaling Peptides and Proteins
Mutation
protein kinase D

Keywords

  • Acinar-to-ductal metaplasia
  • Isoforms
  • Pancreatic cancer
  • Protein kinase D

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Protein kinase D enzymes : Novel kinase targets in pancreatic cancer. / Liou, Geou Yarh; Storz, Peter.

In: Expert Review of Gastroenterology and Hepatology, Vol. 9, No. 9, 02.09.2015, p. 1143-1146.

Research output: Contribution to journalArticle

@article{a7440bb2153f4e5884e5592171fbe05f,
title = "Protein kinase D enzymes: Novel kinase targets in pancreatic cancer",
abstract = "Pancreatic ductal adenocarcinoma (PDA) is characterized by advanced stage desmoplastic tumors with a high prevalence of genetic abnormalities. Occurrence of PDA is linked to activating Kras mutations and aberrant epidermal growth factor receptor signaling, leading to additional activation of wild-type Kras. As Kras is difficult to target, there is a constant need to identify novel targets acting downstream of this molecule in driving the formation or progression of PDA. Recently, it was shown that protein kinase D enzymes not only are increasingly expressed in PDA but also causatively linked to the development and progression of this cancer. They act downstream of both mutant Kras and growth factors and therefore may represent ideal novel targets.",
keywords = "Acinar-to-ductal metaplasia, Isoforms, Pancreatic cancer, Protein kinase D",
author = "Liou, {Geou Yarh} and Peter Storz",
year = "2015",
month = "9",
day = "2",
doi = "10.1586/17474124.2015.1069706",
language = "English (US)",
volume = "9",
pages = "1143--1146",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "9",

}

TY - JOUR

T1 - Protein kinase D enzymes

T2 - Novel kinase targets in pancreatic cancer

AU - Liou, Geou Yarh

AU - Storz, Peter

PY - 2015/9/2

Y1 - 2015/9/2

N2 - Pancreatic ductal adenocarcinoma (PDA) is characterized by advanced stage desmoplastic tumors with a high prevalence of genetic abnormalities. Occurrence of PDA is linked to activating Kras mutations and aberrant epidermal growth factor receptor signaling, leading to additional activation of wild-type Kras. As Kras is difficult to target, there is a constant need to identify novel targets acting downstream of this molecule in driving the formation or progression of PDA. Recently, it was shown that protein kinase D enzymes not only are increasingly expressed in PDA but also causatively linked to the development and progression of this cancer. They act downstream of both mutant Kras and growth factors and therefore may represent ideal novel targets.

AB - Pancreatic ductal adenocarcinoma (PDA) is characterized by advanced stage desmoplastic tumors with a high prevalence of genetic abnormalities. Occurrence of PDA is linked to activating Kras mutations and aberrant epidermal growth factor receptor signaling, leading to additional activation of wild-type Kras. As Kras is difficult to target, there is a constant need to identify novel targets acting downstream of this molecule in driving the formation or progression of PDA. Recently, it was shown that protein kinase D enzymes not only are increasingly expressed in PDA but also causatively linked to the development and progression of this cancer. They act downstream of both mutant Kras and growth factors and therefore may represent ideal novel targets.

KW - Acinar-to-ductal metaplasia

KW - Isoforms

KW - Pancreatic cancer

KW - Protein kinase D

UR - http://www.scopus.com/inward/record.url?scp=84939786723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939786723&partnerID=8YFLogxK

U2 - 10.1586/17474124.2015.1069706

DO - 10.1586/17474124.2015.1069706

M3 - Article

C2 - 26174103

AN - SCOPUS:84939786723

VL - 9

SP - 1143

EP - 1146

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 9

ER -